“…MALT lymphoma is commonly associated with preexisting autoimmune diseases, such as Sjögren's syndrome, or with chronic immune stimulation of the salivary gland, which accounts for 52% of MALT lymphomas in the maxillofacial region. 6 , 7 Several genetic abnormalities that result in the amplification of NF‐κB and NOTCH signaling have been recently reported as possible causes. 8 , 9 For instance, frequently occurring translocations, such as t(11;18)(q21;q21), t(14;18)(q32;q21), and t(1;14)(p22;q32), which deregulate MALT1, BCL10, and BIRC3 have been reported to activate NF‐κB signaling.…”